Frontiers Current Pharmacological Strategies for Duchenne

CRISPR technologies for the treatment of Duchenne muscular dystrophy: Molecular Therapy

hiPSCs To Study And Identify Novel Drug Targets In Duchenne Muscular Dystrophy

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

Stabilizing Ryanodine Receptors Improves Left Ventricular Function in Juvenile Dogs With Duchenne Muscular Dystrophy

Pharmacological advances for treatment in Duchenne muscular dystrophy - ScienceDirect

Frontiers Care for Patients With Neuromuscular Disorders in the COVID-19 Pandemic Era

Therapeutic approaches for Duchenne muscular dystrophy

Breathing in Duchenne muscular dystrophy: translation to therapy - Mhandire - 2022 - The Journal of Physiology - Wiley Online Library

Reprogramming RNA processing: an emerging therapeutic landscape: Trends in Pharmacological Sciences

Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Frontiers DMD Pluripotent Stem Cell Derived Cardiac Cells Recapitulate in vitro Human Cardiac Pathophysiology

A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy

Adjuvant pharmacological strategies for the musculoskeletal system during long‐term space missions - Thomasius - British Journal of Clinical Pharmacology - Wiley Online Library